Simulations Plus Joins European Consortium on Development of Oral Bioavailability Tools (OrBiTo)

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has accepted an invitation and signed a formal agreement to participate in the European Union Oral Bioavailability Tools (OrBiTo) project. Simulations Plus is the only non-European company invited to participate.

Back to news